Back to directory

cell reprogramming & therapeutics LLC

Biotechnology company developing cellular models and therapeutics for neurological disorders.

Wauwatosa, WIFounded 2013

Contact Information

Address

10437 W Innovation Dr Ste 321, Wauwatosa, WI 53226

View on Google Maps

About

Research uses small-molecule chemical genetics to reprogram adult somatic cells into neuronal and glial cell types for disease models, drug and toxicity studies, and cellular therapeutics. Programs address brain and spinal cord injury, stroke, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease, and brain malignancies. The company operates at the Technology Innovation Center in Wauwatosa.

Services

  • Cell reprogramming chemicals
  • Cell reprogramming kits
  • Neuronal differentiation kits
  • Clinical-grade cell production technology
  • High-throughput neurotoxic screening
  • High-throughput neuroprotective screening

Team

Checked Date: Oct 16, 2026
A

Arshak R. Alexanian

VMD, PhD, Associate Professor, Chief Scientific Officer

Oversees company research and administration; trained in veterinary medicine and biochemical pharmacology.

J

James R. Bamburg

PhD, Professor, Colorado State University

Colorado State University professor in biochemistry, molecular biology, and neuroscience.

M

Michael G. Fehlings

MD, PhD, Professor of Neurosurgery, Toronto University

University of Toronto neurosurgery professor researching brain and spinal cord injury.

A

Andrey Sorokin

PhD, Professor, Medical College of Wisconsin

Medical College of Wisconsin professor whose research covers cellular signaling.

L

Levon Gabrielian

MD, PhD, Medical School, University of Adelaide

Physician-scientist with training in pediatrics, neuroscience, and clinical psychology.

B

Brian D. Curry

PhD, MBA, President and Chief Executive Officer at Simply 1Life Inc.

Commercialization consultant trained in cell biology, pharmacology, physiology, and physics.